Haemonetics Profit Margin 2010-2024 | HAE

Current and historical gross margin, operating margin and net profit margin for Haemonetics (HAE) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Haemonetics net profit margin as of December 31, 2024 is 12.32%.
Haemonetics Annual Profit Margins
Haemonetics Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.473B $1.361B
Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $224.526B 27.00
Boston Scientific (BSX) United States $152.309B 38.13
Stryker (SYK) United States $147.916B 30.93
EssilorLuxottica (ESLOY) France $129.703B 0.00
Medtronic (MDT) Ireland $109.157B 15.94
Lonza Group Ag (LZAGY) Switzerland $49.583B 0.00
Haleon (HLN) United Kingdom $47.109B 26.80
ResMed (RMD) United States $36.312B 27.27
GE HealthCare Technologies (GEHC) United States $33.806B 16.05
Agilent Technologies (A) United States $32.907B 21.74
Terumo (TRUMY) Japan $27.953B 0.00
Koninklijke Philips (PHG) Netherlands $22.765B 16.36
Insulet (PODD) United States $22.130B 86.87
Zimmer Biomet Holdings (ZBH) United States $19.288B 12.39
Baxter (BAX) United States $15.985B 11.94
Smith & Nephew SNATS (SNN) United Kingdom $12.381B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.030B 0.00
Bio-Rad Laboratories (BIO) United States $7.091B 23.97
Lantheus Holdings (LNTH) United States $5.462B 13.78
Prestige Consumer Healthcare (PBH) United States $4.298B 19.20
Perrigo (PRGO) Ireland $3.605B 9.14
ICU Medical (ICUI) United States $3.534B 26.06
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.154B 26.21
QuidelOrtho (QDEL) United States $2.401B 16.52
GN Store Nord (GNNDY) Denmark $2.164B 17.92
LeMaitre Vascular (LMAT) United States $1.882B 42.06
AtriCure (ATRC) United States $1.558B 0.00
Neogen (NEOG) United States $1.409B 18.03
AdaptHealth (AHCO) United States $1.217B 12.36
Kestra Medical Technologies (KMTS) United States $1.179B 0.00
Green Thumb Industries (GTBIF) United States $1.172B 26.35
BioLife Solutions (BLFS) United States $1.097B 0.00
InMode (INMD) Israel $1.038B 9.50
Phibro Animal Health (PAHC) United States $0.996B 12.75
Evolus (EOLS) United States $0.653B 0.00
CeriBell (CBLL) United States $0.600B 0.00
Curaleaf Holdings (CURLF) Canada $0.577B 0.00
Owens & Minor (OMI) United States $0.559B 4.63
Valneva SE (VALN) France $0.534B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.524B 0.00
Tilray Brands (TLRY) Canada $0.453B 0.00
Surmodics (SRDX) United States $0.398B 0.00
Cresco Labs (CRLBF) United States $0.350B 0.00
SNDL (SNDL) Canada $0.347B 0.00
Capricor Therapeutics (CAPR) United States $0.333B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Sanara MedTech (SMTI) United States $0.312B 0.00
VAREX IMAGING (VREX) United States $0.309B 11.36
Aurora Cannabis (ACB) Canada $0.290B 51.60
Sanuwave Health (SNWV) United States $0.285B 0.00
Viemed Healthcare (VMD) United States $0.272B 22.97
Canopy Growth (CGC) Canada $0.267B 0.00
Omeros (OMER) United States $0.258B 0.00
Verano Holdings (VRNOF) United States $0.255B 0.00
Cerus (CERS) United States $0.250B 0.00
ZimVie (ZIMV) United States $0.248B 11.28
Biote (BTMD) United States $0.214B 6.02
OraSure Technologies (OSUR) United States $0.198B 0.00
High Tide (HITI) Canada $0.186B 0.00
Brainsway (BWAY) Israel $0.185B 49.05
Quanterix (QTRX) United States $0.180B 0.00
Utah Medical Products (UTMD) United States $0.180B 14.47
Organigram Global (OGI) Canada $0.166B 0.00
TriSalus Life Sciences (TLSI) United States $0.164B 0.00
FitLife Brands (FTLF) United States $0.148B 18.19
Jin Medical (ZJYL) China $0.133B 0.00
Exagen (XGN) United States $0.120B 0.00
TerrAscend (TSNDF) Canada $0.116B 0.00
Agape ATP (ATPC) $0.101B 0.00
MacroGenics (MGNX) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
Fonar (FONR) United States $0.077B 10.71
Veru (VERU) United States $0.076B 0.00
Quipt Home Medical (QIPT) United States $0.072B 0.00
InterCure (INCR) Israel $0.070B 0.00
Jushi Holdings (JUSHF) United States $0.070B 0.00
Zynex (ZYXI) United States $0.066B 0.00
United Health Products (UEEC) United States $0.061B 0.00
Apyx Medical (APYX) United States $0.060B 0.00
Cytosorbents (CTSO) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Modular Medical (MODD) United States $0.040B 0.00
United-Guardian (UG) United States $0.037B 12.94
Rockwell Medical (RMTI) United States $0.037B 0.00
Safety Shot (SHOT) United States $0.034B 0.00
Nephros (NEPH) United States $0.023B 0.00
INLIF (INLF) $0.020B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00